Tumor-Derived Transforming Growth Factor-β is Critical for Tumor Progression and Evasion from Immune Surveillance |
Li, Zheng
(State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University)
Zhang, Li-Juan (Tianjin Medical University) Zhang, Hong-Ru (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Tian, Gao-Fei (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Tian, Jun (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Mao, Xiao-Li (Department of Immunology, School of Basic Medical Science, Wuhan University) Jia, Zheng-Hu (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Meng, Zi-Yu (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Zhao, Li-Qing (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Yin, Zhi-Nan (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) Wu, Zhen-Zhou (State Key Laboratory of Medical Chemical Biology, College of Life Sciences, Nankai University) |
1 | Zou W (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol, 6, 295-307. DOI ScienceOn |
2 | Willimsky G, Blankenstein T (2005). Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature, 437, 141-6. DOI ScienceOn |
3 |
Yamazaki S, Iyoda T, Tarbell K, et al (2003). Direct expansion of functional |
4 |
Yang L, Huang J, Ren X, et al (2008). Abrogation of TGF beta signaling in mammary carcinomas recruits |
5 |
Liu CY, Wang YM, Wang CL, et al (2010). Population alterations of L-arginase- and inducible nitric oxide synthase-expressed |
6 | Kulkarni AB, Huh CG, Becker D, et al (1993). Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A, 90, 770-4. DOI ScienceOn |
7 | Li MO, Flavell RA (2008). TGF-beta: a master of all T cell trades. Cell, 134, 392-404. DOI ScienceOn |
8 | Li Z, Chen L, Rubinstein MP (2013). Cancer immunotherapy: are we there yet? Exp Hematol Oncol, 2, 33. DOI ScienceOn |
9 | Massague J (2008). TGFbeta in Cancer. Cell, 134, 215-30. DOI ScienceOn |
10 | McKarns SC, Schwartz RH, Kaminski NE (2004). Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol, 172, 4275-84. DOI |
11 | Siegel PM, Massague J (2003). Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer, 3, 807-21. DOI ScienceOn |
12 | Thomas DA, Massague J (2005). TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell, 8, 369-80. DOI ScienceOn |
13 |
Chen W, Jin W, Hardegen N, et al (2003). Conversion of peripheral |
14 | Tripsianis G, Papadopoulou E, Romanidis K (2013). Overall survival and clinicopathological characteristics of patients with breast cancer in relation to the expression pattern of HER-2, IL-6, TNF-alpha and TGF-beta1. Asian Pac J Cancer Prev, 14, 6813-20. 과학기술학회마을 DOI ScienceOn |
15 | Curiel TJ, Coukos G, Zou L, et al (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 10, 942-9. DOI ScienceOn |
16 |
Centuori SM, Trad M, LaCasse CJ, et al (2012). Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-beta-induced differentiation of |
17 | Chung DJ, Rossi M, Romano E, et al (2009). Indoleamine 2, 3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood, 114, 555-63. DOI ScienceOn |
18 |
Donkor MK, Sarkar A, Li MO (2012). Tgf-beta1 produced by activated |
19 | Gorelik L, Flavell RA (2001). Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med, 7, 1118-22. DOI ScienceOn |
20 | Hu JL, Yang Z, Tang JR, et al (2013). Effects of gastric cancer cells on the differentiation of Treg cells. Asian Pac J Cancer Prev, 14, 4607-10. 과학기술학회마을 DOI ScienceOn |
21 | Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ (2000). Early detection and treatment of skin cancer. Am Fam Physician, 62, 357-68, 75-6, 81-2. |
22 | Akhurst RJ, Derynck R (2001). TGF-beta signaling in cancer--a double-edged sword. Trends Cell Biol, 11, 44-51. |
23 | Bierie B, Moses HL (2006). Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer, 6, 506-20. DOI ScienceOn |
24 | Buck MB, Fritz P, Dippon J, et al (2004). Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res, 10, 491-8. DOI ScienceOn |
25 |
Ghiringhelli F, Puig PE, Roux S, et al (2005). Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing |
26 | Marigo I, Dolcetti L, Serafini P, et al (2008). Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev, 222, 162-79. DOI ScienceOn |
![]() |